Notice of Interim Results

Spire Healthcare Group PLC

21 July 2026

 

21 July 2026

Spire Healthcare Group plc

("Spire Healthcare", the "Company")

Notice of Interim Results

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, will announce its interim results for the six months ended 30 June 2026 on 9 September 2026.

ENQUIRIES:

For further information please contact:

Spire Healthcare Group plc Amie Gramlick, Director of Commercial Finance & Investor Relations	[phone]
Brunswick (Communications adviser) Simon Sporborg / Ayesha Bharmal	[phone]
J.P. Morgan Cazenove (Financial adviser and joint corporate broker) James Mitford / Alia Malik / Nikhil Gondalia	[phone]
Berenberg (Joint corporate broker) Toby Flaux / Ben Wright / Detlir Elezi	[phone]

About Spire Healthcare

Spire Healthcare is a leading, independent healthcare group in the United Kingdom, running 38 hospitals and over 60 clinics across England, Wales and Scotland. Working in partnership with over 8,800 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1.36 million inpatients, outpatients and day case patients, and workplace health clients, in 2025. It is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

It operates a network of private GPs and provides workplace health services to over 1,400 employers. It also delivers a range of private, NHS and employer-funded mental health, musculoskeletal and 3 dermatological services, and is the largest independent provider of NHS talking therapies in England.

Spire Healthcare's almost 100 well-located clinical sites deliver award-winning care for self-pay patients, the NHS, employers and private medical insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding', or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

 

END